FDA.reportPublic FDA data

alyftrek 125 MG / 50 MG / 10 MG Oral Tablet

RxCUI
2701444
RxNorm name
alyftrek 125 MG / 50 MG / 10 MG Oral Tablet
Display name
alyftrek 125 MG / 50 MG / 10 MG Oral Tablet
Full name
alyftrek 125 MG / 50 MG / 10 MG Oral Tablet
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:05

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
ALYFTREKVANZACAFTOR, TEZACAFTOR, AND DEUTIVACAFTORVertex Pharmaceuticals Incorporated7e635909-c6fd-4f0d-ae77-cdff03653a202026-08-26Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 2701444

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
7e635909-c6fd-4f0d-ae77-cdff03653a20alyftrek 125 MG / 50 MG / 10 MG Oral Tablet [PSN] · deutivacaftor 125 MG / tezacaftor 50 MG / vanzacaftor 10 MG Oral Tablet [Alyftrek] [SBD] · Alyftrek 125 MG / 50 MG / 10 MG (equivalent to vanzacaftor calcium dihydrate 10.6 MG) Oral Tablet [SY]38These highlights do not include all the information needed to use ALYFTREK safely and effectively. See full prescribing information for ALYFTREK. ALYFTREK (vanzacaftor, tezacaftor, and deutivacaftor tablets), for oral use Initial U.S. Approval: 202420260323